Abstract
Presented at the Midyear Clinical Meeting.
Findings of this evaluation suggest opportunities to improve terlipressin utilization by sharing results back to Nephrology and GI and
reviewing P&T-approved criteria for use, implementing EMR alerts to reinforce dosing
protocols every 24-48 hours for dose adjustments
or discontinuation based on Scr trends (day 4 and
beyond), and supporting daily monitoring of fluid
and respiratory status.
Findings of this evaluation suggest opportunities to improve terlipressin utilization by sharing results back to Nephrology and GI and
reviewing P&T-approved criteria for use, implementing EMR alerts to reinforce dosing
protocols every 24-48 hours for dose adjustments
or discontinuation based on Scr trends (day 4 and
beyond), and supporting daily monitoring of fluid
and respiratory status.
Document Type
Poster
Publication Date
2025
Recommended Citation
Beckett, Robert D. PharmD, "Evaluation of terlipressin use at a community health system" (2025). Parkview Pharmacy Department. 109.
https://researchrepository.parkviewhealth.org/pharma/109